Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Gritstone Oncology Inc. (GRTS)

10.45   -0.6 (-5.43%) 07-16 16:00
Open: 11.1 Pre. Close: 11.05
High: 11.1 Low: 10.31
Volume: 142,545 Market Cap: 373M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.302 - 11.363 11.363 - 11.415
Low: 10.722 - 10.798 10.798 - 10.861
Close: 10.934 - 11.051 11.051 - 11.149

Technical analysis

as of: 2019-07-16 3:21:15 PM
Overall:       
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 13.25     One year: 14.71
Support: Support1: 9.33    Support2: 7.76
Resistance: Resistance1: 11.34    Resistance2: 12.59
Pivot: 11.07
Moving Average: MA(5): 11.42     MA(20): 10.94
MA(100): 11.54     MA(250):
MACD: MACD(12,26): 0.23     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 44.52     %D(3): 63.44
RSI: RSI(14): 45.59
52-week: High: 32.90  Low: 8.75  Change(%): -26.3
Average Vol(K): 3-Month: 27155  10-Days: 14352

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GRTS has closed above bottom band by 29.4%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 17 May 2019 23:08:28 Z
US IPO Week Ahead: Permian pipelines go public alongside 3 cancer biotechs

Thu, 25 Apr 2019 17:14:17 Z
Why Gritstone Oncology Stock Is Sinking Today

Sat, 15 Dec 2018 14:07:01 Z
3 Biotechs Gilead Sciences Could Buy in March

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35.72
Shares Float (M) 18.17
% Held by Insiders 7.27
% Held by Institutions 70.03
Shares Short (K) 2300
Shares Short P. Month (K)

Stock Financials

EPS -4.450
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Book Value (p.s.) 4.560
PEG Ratio
Profit Margin
Operating Margin -2804.81
Return on Assets (ttm) -32.7
Return on Equity (ttm) -60.5
Qtrly Rev. Growth
Gross Profit (p.s.) -1.506
Sales Per Share
EBITDA (p.s.) -1.875
Qtrly Earnings Growth
Operating Cash Flow (M) -42.23
Levered Free Cash Flow (M) -37.98

Stock Valuations

P/E -2.36
P/E Growth Ratio -0.05
P/BV 2.30
P/S 2341892608.00
P/CF -8.87

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.